Showing results (1441-1450 of 2,530) with videos related to

Sort By:
Pageof 253
Neurology|September 29, 2017
Brain network connectivity differs in early-onset neurodegenerative dementiaMassimo Filippi, Silvia Basaia, Elisa Canu, et al.
Journal of Neurology|May 2, 2013
Fingolimod versus intramuscular interferon in patient subgroups from TRANSFORMSJeffrey A Cohen, Frederik Barkhof, Giancarlo Comi, et al.
Magnetic Resonance Imaging|December 28, 1999
Method for intracellular magnetic labeling of human mononuclear cells using approved iron contrast agentsJ C Sipe, M Filippi, G Martino, et al.
Plos One|June 24, 2016
Motor Cortical Plasticity to Training Started in Childhood: The Example of Piano PlayersRaffaella Chieffo, Laura Straffi, Alberto Inuggi, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 28, 2019
Effects of Natalizumab and Fingolimod on Clinical, Cognitive, and Magnetic Resonance Imaging Measures in Multiple SclerosisPaolo Preziosa, Maria A Rocca, Gianna C Riccitelli, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1984
Embryonic----Fetal Hb switch in humans: studies on erythroid bursts generated by embryonic progenitors from yolk sac and liverC Peschle, A R Migliaccio, G Migliaccio, et al.
Brain : a Journal of Neurology|June 25, 2005
Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesisMarina Scarlato, Stefano Carlo Previtali, Marinella Carpo, et al.
Journal of Alzheimer'S Disease : JAD|September 10, 2014
A global immune deficit in Alzheimer's disease and mild cognitive impairment disclosed by a novel data mining processMaira Gironi, Bruno Borgiani, Elisabetta Farina, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 22, 2021
Cell-penetrating peptide-conjugated Morpholino rescues SMA in a symptomatic preclinical modelMargherita Bersani, Mafalda Rizzuti, Elisa Pagliari, et al.
Orphanet Journal of Rare Diseases|May 15, 2026
Combined omalizumab and desensitization to control IgE-mediated hypersensitivity in enzyme replacement therapy for late-onset Pompe diseaseAlberto Lerario, Elena Abati, Monica Sciacco, et al.
Pageof 253